DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Twenty-year follow-up of a randomized prospective clinical trial of excimer laser photorefractive keratectomy.

Author(s): O'Brart DP(1), Shalchi Z(2), McDonald RJ(2), Patel P(2), Archer TJ(3), Marshall J(4).

Affiliation(s): Author information: (1)Keratoconus Research Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom. Electronic address: davidobrart@aol.com. (2)Keratoconus Research Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom. (3)London Vision Clinic, London, United Kingdom. (4)Moorfields Biomedical Research Centre, University College, London Institute of Ophthalmology, London, United Kingdom.

Publication date & source: 2014, Am J Ophthalmol. , 158(4):651-663

PURPOSE: To investigate the 20-year efficacy and safety of photorefractive keratectomy (PRK). DESIGN: Long-term observational case series. METHODS: In the setting of a university hospital, a study population of 42 patients (42 eyes) who had, as part of a randomized prospective trial, undergone PRK 20 years previously were studied. All had received -3.0 or -6.0 diopter (D) corrections with either 5.0 or 6.0 mm optical zones or a multizone treatment. The mean preoperative spherical equivalent refractive error (SEQ) was -5.13 D (range, -2.75 to -8.0 D). The outcome measures included visual acuity, refractive error, corneal topography and axial length. RESULTS: Between 1 and 20 years there was an increase in mean myopic SEQ of -0.54 D (P < 0.02). In patients younger than 40 years of age at time of correction, this increase was -0.92 D (P < 0.002) with an accompanying increase in variance (P < 0.02), whereas in those older than 40 it was -0.08D (P = 0.8). In female patients the change was -0.69D (P < 0.01), while in males it was -0.26D (P = 0.6). The efficacy index at 20 years was 0.49, and the safety index was 0.97. Corrected distance visual acuity improved between 1 and 20 years (P < 0.01); 93% of corneas were clear at 20 years; 3 eyes had trace haze. There was an improvement in haze scores between 1 and 20 years (P < 0.02). Cornea power remained unchanged between 6 months and 20 years (P = 0.4). Axial length increased by a mean of 0.84 mm (P < 0.0001). There was no ectasia. CONCLUSIONS: There was a slight but significant increase in myopic SEQ after PRK between 1 and 20 years, particularly in those under 40 at the time of treatment and in female patients. Corneal power remained unchanged, but axial length increased. The procedure was safe, with no long-term sight-threatening complications and with improvements in corrected distance visual acuity and corneal transparency with time.

Page last updated: 2014-11-30

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017